A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma

A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma

BackgroundHepatocellular carcinoma is one of the most common malignant tumors with a very high mortality rate. The emergence of immunotherapy has brought hope for the cure of hepatocellular carcinoma. Only a small number of patients respond to immune checkpoint inhibitors, and ferroptosis and tertia...

Full description

Bibliographic Details
Main Authors: Ye Nie, Jianhui Li, Wenlong Wu, Dongnan Guo, Xinjun Lei, Tianchen Zhang, Yanfang Wang, Zhenzhen Mao, Xuan Zhang, Wenjie Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
prognosis
tumor-infiltrating lymphocytes
immunotherapy response
tertiary lymphoid structure
ferroptosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.706915/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.706915/full

Similar Items